Event guide: The 9th DDR Inhibitors Summit 2026

https://www.news-medical.net/industry-focus/Event-guide-The-9th-DDR-Inhibitors-Summit-2026?utm_source=azonetwork_newsletter&utm_medium=email&utm_campaign=cell_biology_newsletter_9_december_2025 The DNA Damage Response (DDR) field is entering a defining new phase. With PARP inhibitors firmly established in the clinic, attention is turning toward next-generation DDR targets – including ATR, CHK1/2, DNA-PK, and WEE1 – and the biomarker-driven combination strategies that promise to unlock greater selectivity, durability, and reduced toxicity.